Descrizione

Summary of efficacy and safety outcomes from the microneedling combination therapy trial, supporting its clinical utility for hair loss management.

Fig. 13

Chart

Source Paper

Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis.

Archives of dermatological research (2025)

PMID: 40056230

DOI: 10.1007/s00403-025-04032-1

Cite This Figure

![Fig. 13: Summary of efficacy and safety outcomes from the microneedling combination therapy trial, supporting its clinical utility for hair loss management.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890238/bin/403_2025_4032_Fig13_HTML.jpg)

> Source: Khalid M A Ahmed et al. "Evaluating the efficacy and safety of combined microneedling therapy versus topi." *Archives of dermatological research*, 2025. PMID: [40056230](https://pubmed.ncbi.nlm.nih.gov/40056230/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890238/bin/403_2025_4032_Fig13_HTML.jpg" alt="Summary of efficacy and safety outcomes from the microneedling combination therapy trial, supporting its clinical utility for hair loss management." />
  <figcaption>Fig. 13. Summary of efficacy and safety outcomes from the microneedling combination therapy trial, supporting its clinical utility for hair loss management.<br>  Source: Khalid M A Ahmed et al. "Evaluating the efficacy and safety of combined microneedling therapy versus topi." <em>Archives of dermatological research</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40056230/">40056230</a></figcaption>
</figure>

Evidenze correlate

Minoxidil per Alopecia androgenetica

Grado A · 299 studi

Microneedling per Alopecia androgenetica

Grado A · 62 studi